ReviewJournal of hematology2017

Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes.

Lei Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.